Replies to post #199 on Aratana Therapeutics Inc (fka PETX)

[kris_kade]

It is under accumulation with uptrend back to $8+ support area.

A sharp breakout likely when Entyce drug is launched early 2017. Big catalyst. I expect 1q17 cc to be pivotal for the company unless they ink another deal with Elanco or someone else before than.